Shares of West Pharmaceutical Services Inc. rallied 3.38% to $218.58 Thursday, on what proved to be an all-around grim ...

West Pharmaceutical Services, Inc.'s lumpy performance, declining profits & high valuation raise concerns. Click for why WST ...

West Pharmaceutical Services shares have dropped 35% in 2025, despite better-than-expected Q1 results, with forward guidance ...

Looking at West Pharmaceutical Services’s peers in the life sciences tools & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Medpace ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. With a market cap ...

From serialization and sustainability to patient-centric design, experts reveal the trends shaping the contract packaging ...

Shares of West Pharmaceutical Services Inc. WST slid 4.25% to $206.69 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0. ...

West Pharmaceutical Services gets about half of it sales from markets outside of the United States. Hospital sale generates $11M for suburban health system © 2025 ...

Pharma companies are expending considerable time, energy and money on developing services that are designed to support patients before, during and after treatment across therapeutic areas.

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know. West Pharmaceutical Services beat ...